CAI
Caris Life Sciences, Inc.
27.50$
+1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 34.5% | 33.6% | 34.6% | 36.3% | 37.1% | 41.6% | 80.6% | 44.8% | 48.3% | 61.1% | 57.4% | 55.3% | 52.9% | 50.6% | 47.5% | 49.8% | 50.8% | 50.9% | 50.5% | 50.7% | 51.9% | 51.9% | 52.5% | 51.3% | 38.1% | 38.5% | 36.6% | 52.2% | 50.0% | 46.4% | 67.6% | 62.5% | 56.3% | 45.6% | 52.8% | 37.3% | 32.0% | 24.6% | 34.6% | 31.9% | 30.3% | |
| 65.5% | 66.4% | 65.4% | 63.7% | 62.9% | 58.4% | 19.4% | 55.2% | 51.7% | 38.9% | 42.6% | 44.7% | 47.1% | 49.4% | 52.5% | 50.2% | 49.2% | 49.1% | 49.5% | 49.3% | 48.1% | 48.1% | 47.5% | 48.7% | 61.9% | 61.5% | 63.4% | 47.8% | 100.0% | 53.6% | 32.4% | 37.5% | 43.7% | 54.4% | 47.2% | 62.7% | 68.0% | 75.4% | 65.4% | 68.1% | 69.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 42.6% | 24.8% | 27.2% | 20.9% | 19.1% | 13.8% | 10.0% | 10.9% | 2.5% | 12.3% | 9.2% | |
| – | – | – | – | – | – | 9.3% | 13.1% | 12.5% | 14.1% | 9.0% | 13.1% | 11.8% | 12.0% | 12.2% | 11.8% | 11.5% | 11.1% | 12.1% | 13.0% | 11.7% | 11.8% | 14.6% | 11.3% | 9.8% | 8.1% | 9.1% | 9.6% | 11.9% | 12.2% | 56.4% | 41.0% | 40.2% | 28.0% | 44.1% | 35.5% | 24.0% | 19.3% | 27.6% | 25.2% | 23.7% | |
| 24.0% | 22.5% | 22.4% | 23.9% | 23.6% | 23.4% | 22.0% | 26.6% | 25.5% | 25.3% | 20.2% | 21.6% | 19.3% | 15.8% | 16.8% | 16.1% | 14.0% | 14.2% | 15.9% | 17.6% | 15.5% | 16.2% | 19.5% | 16.7% | 18.3% | 16.5% | 7.3% | 9.6% | 40.7% | 12.2% | 146.7% | -29.4% | 103.6% | 82.9% | 95.1% | 52.8% | 53.0% | 45.2% | 62.9% | 57.9% | 54.2% | |
| 41.5% | 43.9% | 42.9% | 39.8% | 39.3% | 35.1% | -2.6% | 28.7% | 26.2% | 13.6% | 22.4% | 23.1% | 27.8% | 33.5% | 35.7% | 34.1% | 35.2% | 34.9% | 33.6% | 31.8% | 32.6% | 32.0% | 28.1% | 32.0% | 43.6% | 45.0% | 56.1% | 60.4% | 59.3% | 65.9% | -114.3% | 67.0% | -59.9% | -28.5% | -47.9% | 9.9% | 15.1% | 30.2% | 2.4% | 10.2% | 15.5% | |
| 16.1% | 15.6% | 14.1% | 15.0% | 15.2% | 13.6% | 14.1% | 14.9% | 14.7% | 13.8% | 14.7% | 14.3% | 14.9% | 15.5% | 16.1% | 17.7% | 17.4% | 17.1% | 20.1% | 21.5% | 19.0% | 18.7% | 19.1% | 19.4% | 23.2% | 21.0% | 10.8% | 13.8% | 13.0% | – | 11.5% | 13.7% | 13.6% | 10.2% | 10.6% | 10.6% | 6.2% | 3.9% | 5.9% | 3.5% | 4.7% | |
| 28.0% | 30.3% | 31.6% | 25.5% | 23.6% | 21.6% | -18.2% | 12.4% | 5.8% | -4.6% | 1.3% | 7.3% | 15.2% | 19.4% | 22.5% | 18.7% | 19.9% | 19.9% | 17.0% | 18.2% | 15.0% | 15.2% | 9.2% | -4.4% | 0.6% | 21.2% | 25.9% | 46.0% | 46.4% | 54.4% | -137.6% | -66.2% | -66.6% | -28.4% | -84.8% | -39.6% | 11.2% | 28.0% | -0.3% | -0.2% | 10.6% | |
| 3.6% | 2.5% | 4.0% | 2.3% | 1.8% | 1.9% | 0.9% | 1.7% | 0.5% | 2.3% | 0.7% | 0.9% | -0.1% | -0.1% | -16.4% | 0.7% | 0.7% | 1.1% | 0.2% | 1.5% | 1.3% | 1.1% | 1.3% | -3.1% | 1.5% | 1.7% | 3.7% | 3.1% | 2.2% | 3.6% | – | – | – | – | – | – | – | – | -0.1% | 0.0% | – | |
| 24.3% | 27.7% | 27.5% | 23.2% | 21.7% | 19.6% | -19.2% | 10.7% | 5.2% | -6.9% | 0.6% | 6.5% | 15.3% | 19.5% | 38.9% | 18.0% | 19.2% | 18.8% | 16.8% | 16.7% | 8.8% | -4.4% | 7.8% | -1.3% | -0.8% | 19.5% | 22.1% | 44.2% | 44.3% | 50.7% | -137.6% | -66.2% | -66.6% | -28.4% | -84.8% | -39.6% | 11.2% | 28.0% | -0.2% | -0.2% | 10.6% | |
| 78.8% | 79.8% | 80.5% | 77.1% | 76.1% | 69.6% | 68.6% | 61.9% | 55.0% | 48.0% | 52.7% | 56.9% | 63.4% | 66.3% | 69.0% | 67.3% | 65.7% | 64.6% | 65.0% | 68.7% | 58.4% | 61.0% | 53.9% | 41.4% | 83.5% | 82.9% | 126.4% | 95.4% | 59.4% | 87.0% | -104.2% | -40.9% | -49.5% | -21.5% | -68.4% | -25.5% | 19.7% | 33.3% | 8.0% | 5.7% | 17.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.